GlassScriptPhysician profile
Jenna Brewer
NPI 1679167738
$1,039.42
in general payments reported to CMS, 2019-2025
21 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $175 · 2023: $430 · 2024: $230 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $105.57 | 2023-2025 | Winrevair, Zerbaxa, Recarbrio |
| Genzyme Corporation | $101.89 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.94 | 2023 | Ofev |
| Astrazeneca Pharmaceuticals LP | $87.55 | 2022-2024 | |
| United Therapeutics Corporation | $79.78 | 2023-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $72.81 | 2022-2023 | Yupelri |
| Janssen Pharmaceuticals, INC | $66.12 | 2023-2024 | Xarelto |
| Grifols USA, LLC | $63.21 | 2022-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $60.39 | 2022-2025 | Dupixent |
| Axsome Therapeutics, INC. | $46.35 | 2023 | Sunosi |
| Atricure, INC. | $38.36 | 2024 | |
| Amgen INC. | $35.72 | 2023 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $31.64 | 2025 | Glassia |
| Horizon Therapeutics Plc | $27.71 | 2023 | Tepezza |
| Pulmonx Corporation | $23.58 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $19.76 | 2025 | Zemaira |
| Electromed, INC. | $18.59 | 2023 | Smartvest |
| Kyowa Kirin, INC. | $17.50 | 2023 | Crysvita |
| Ibsa Pharma INC. | $16.36 | 2022 | |
| Viatris Specialty LLC | $15.66 | 2025 | Yupelri |
| Alexion Pharmaceuticals, INC. | $12.93 | 2023 | Strensiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.